Rezultati pretraživanja
  1. 14. sij

    ❗The latest for venous in patients with solid tumors from the Italian Association of Medical Oncology () have been released. Check the summary on !

  2. 26. pro 2019.

    There is convincing evidence that, taking all factors into account, is an effective, inexpensive, and safe form of venous () following in patients without a major risk factor for VTE, such as previous VTE

  3. There si opportunity for clinicians to enhance the experience of related venous by improving communication and information given to patients, clarifying diagnosis and treatment pathways and improving awareness of the condition.

  4. & : <50% w/ LA thrombus have known ♥️amyloid + concomitant = ⬆️risk of than no ♥️amyloid regardless of (score performs poorly in amyloid) B-blocker ineffective 4 rate control (try amio)

  5. Use of is associated w/ incident venous (VTE). Read this article to learn if these agents also increase the risk of recurrent in individuals w/ previous thromboembolic events.

  6. Our January issue is out! -> for R/R classic , vs. for preventing recurrent venous and bleeding, immune-related adverse events associated with anti-PD(L)1, and more at

  7. 6. sij 2019.

    The combination of plus does not improve either mortality or risk but may increase the risk of bleeding compared with aspirin only for patients with bAVR.

  8. 3. kol 2018.

    The number of arthroplasties being performed increases each year and there is now convincing that is an , & form of venous following

  9. 20. lip 2018.

    JUNE ISSUE: Prevalence and Predictors of Preoperative Venous in Asymptomatic Patients Undergoing Major .

  10. 13. lip 2018.

    What is the association of perioperative red blood cell transfusions with venous ? Find out

  11. 22. svi 2018.

    A study from and colleagues investigates Podoplanin, IDH1 and VTE risk in brain tumors.

  12. 21. svi 2018.

    Our latest in press - vs after on . DOAC resumption not a/w recurrent GIB or TE. Prior VTE predicted future TE, whereas use of DOAC+plavix predicted recurrent GIB. Thx to colleagues @ArielaLMarshall

  13. 3. sij 2018.
  14. 24. lis 2017.

    ICM focus on and bleeding. Venous - bleeding risk - hemorrhagic

  15. 18. ruj 2017.
  16. 7. kol 2017.

    Preventing venous after surgery: a page infographic.

  17. 12. ožu 2017.

    The ICM research agenda on - in , , CVC cannulation, resuscitation.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.